Metabolic alteration in patients with cancer: nutritional implications.
During the past 20 years, efforts have been made to elucidate the metabolic changes observed in patients with cancer by using stable and radioactive isotopic tracers. These metabolic changes in patients with cancer may be similar to those in other stress conditions, in which glucose production and utilization, lipolysis and free fatty acid flux, and net protein catabolism are increased. Stress hormones, such as glucagon and catecholamines, and certain cytokines may be responsible for these metabolic changes. Although it has been shown that cachexia in patients with cancer signals a poor prognosis, efforts to improve the clinical outcomes with nutritional support have been disappointing. The failure of cancer patients to respond to nutritional support may be related to an alteration in the intermediate metabolism. Therefore, further research evaluating the metabolic abnormalities associated with cancer may lead to more effective nutritional therapies.
Sakurai
Y
Y
Department of Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Klein
S
S
D002100:Cachexia / Q000503:physiopathology*; D016207:Cytokines / Q000502:physiology; D004703:Endocrine System / Q000502:physiology; D005947:Glucose / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D009369:Neoplasms / Q000150:complications* / Q000201:enzymology / Q000276:immunology; D009752:Nutritional Status; D018529:Nutritional Support; D011506:Proteins / Q000378:metabolism; D011877:Radionuclide Imaging
D016207:Cytokines; D011506:Proteins; D005947:Glucose